Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide

Details for Australian Patent Application No. 2010247215 (hide)

Owner Sanofi

Inventors Baurin, Nicolas; Blanche, Francis; Cameron, Beatrice; Duchesne, Marc; Mikol, Vincent; Naimi, Souad; Pradier, Laurent; Shi, Yi

Agent Watermark

Pub. Number AU-A-2010247215

PCT Pub. Number WO2010/130946

Priority 0953133 12.05.09 FR

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/130946 Priority application(s): WO2010/130946

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247229-Method for transferring fluids between a first ship and a second ship, and transfer system for implementing said method

2010247214-7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof